Product Information
INFED 100 MG/2 ML VIAL is a brand product labeled by Allergan, Inc., priced at $18.8760 per ML under NDC 00023608210. Its NADAC has been published 105 times since Aug 21, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BP.
Strength
50 mg/mL
Manufacturer
Allergan, Inc.NDC
00023608210
Classification
Brand
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
IRON DEXTRANApproval Type
New Drug (NDA)
FDA Application
NDA017441FDA Approved
Before 1982
TE Code
BP
On Market Since
4/29/1974
Pharmacological Classes
Price Statistics
The NADAC for INFED 100 MG/2 ML VIAL has been published 105 times since Aug 21, 2024, and over the history we have for it it has risen 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.8760 per ML |
|---|---|
| All-time high | $18.9002 (Jul 15, 2026) |
| All-time low | $17.2016 (Sep 18, 2024) |
| 52-week high | $18.9002 |
| 52-week low | $18.0002 |
| Median price | $18.0731 |
| Average price | $18.1449 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 105 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Iron Dextran market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INFED 100 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for INFED 100 MG/2 ML VIAL, manufactured by Allergan, Inc., is $18.8760 per ML (NDC 00023608210), effective Aug 19, 2026.
How has the price of INFED 100 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for INFED 100 MG/2 ML VIAL has risen 9.5%. It has been tracked across 105 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for INFED 100 MG/2 ML VIAL?
Since Aug 21, 2024, the NADAC for INFED 100 MG/2 ML VIAL has ranged from a low of $17.2016 (Sep 18, 2024) to a high of $18.9002 (Jul 15, 2026), with a median of $18.0731 per ML.
Are there cheaper alternatives to INFED 100 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of INFED 100 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INFED 100 MG/2 ML VIAL?
INFED 100 MG/2 ML VIAL (NDC 00023608210) is labeled by Allergan, Inc., and CMS classifies it as a brand product.